Effects of Transcutaneous and Percutaneous PTNS on Idiopathic OAB

Both therapies have been proven to be effective, but very few times have been compared. PTNS and TENS SNS have been proven effective modifying bladder diary scores (change in the frequency of day and night urination, and urge incontinence), and improving subject's quality of life. Only PTNS has shown changes in urodynamic data while undergoing therapy.

The investigators hypothesize that short-term effectiveness and benefit reported, is not lower in the TENS group, if we compare both therapies in a randomized control trial.

Secondary goals are to evaluate changes in bladder diary scores (frequency of urination, nocturia, number of urgency and leakage episodes ), participants quality of life improvement scores and treatment benefit score at TBS scale, while undergoing these therapies.

Inclusion criteria

• Female and male
• Age >18 years
• Complaint urge urinary incontinence (3 or more episodes per week) OR overactive bladder (8 or more voids per day, and/or 2 or more voids per night)
• Urodynamic data of overactive detrusor
• Failed trial of conservative therapy (bladder training, fluid modification, diet modification, caffeine restriction, pelvic floor training)
• Failed trial of anticholinergic either due to inability to take the medication, adverse reaction to medication, or no improvement on medication
• Willing to complete study questionnaires and informed consent study

Exclusion criteria

• Presence of bladder obstruction (prostate or prolapse)
• Neurogenic bladder overactivity
• Previous pelvic organ prolapse surgery
• Unwilling and mentally incompetent to participate in study
• Pregnancy or planning to become pregnant during the study
• Presence of urinary fistula
• Recurrent or current urinary tract infection (5 or more infections in the last 12 months)
• Bladder stones
• Bladder cancer or suspected bladder cancer
• Hematuria
• Central or peripheral neurologic disorders such as Multiple Sclerosis, Parkinson's disease, spina bifida, or other spinal cord lesion
• Metal implants such as pacemaker, implantable defibrillator, or metal implants where PTNS or TENS device needs to be placed (sacrum or ankle/leg).
• Uncontrolled diabetes and diabetes with peripheral nerve involvement
• Anticoagulants treatment
• Current use of anticholinergics or use within the last 4 weeks
• Current use of botox bladder injections or bladder botox injection within the last year
• Current use of interstim therapy or currently implanted interstim device or leads
• Urinary retention or gastric retention
• Painful Bladder Syndrome/Interstitial Cystitis
• Previous PTNS treatment